These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19691214)

  • 1. Glycaemic control and macrovascular complications of type 2 diabetes.
    Dandona P; Chaudhuri A
    Natl Med J India; 2008; 21(6):271-4. PubMed ID: 19691214
    [No Abstract]   [Full Text] [Related]  

  • 2. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M; Jialal I
    Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes and hypertension. Results from the ADVANCE study].
    Mehlsen J
    Ugeskr Laeger; 2008 Feb; 170(7):531-2. PubMed ID: 18291082
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular complications in diabetes mellitus.
    Sobel BE; Schneider DJ
    Curr Opin Pharmacol; 2005 Apr; 5(2):143-8. PubMed ID: 15780822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].
    MMW Fortschr Med; 2003 Jan; 145(3-4):54-5. PubMed ID: 12619235
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
    Goodarzi MO; Psaty BM
    JAMA; 2008 Nov; 300(17):2051-3. PubMed ID: 18984894
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of macrovascular disease in type 2 diabetes. Role of insulin resistance.
    Stern M
    Diabetes Care; 1999 Apr; 22 Suppl 3():C2-5. PubMed ID: 10189555
    [No Abstract]   [Full Text] [Related]  

  • 11. [Review of the cooperative study of Veterans' affairs on the control and complications of type 2 diabetes, especially cardiovascular diseases].
    Nuttall FQ
    Journ Annu Diabetol Hotel Dieu; 1998; ():99-112. PubMed ID: 9773613
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetic vascular disease.
    Feingold KR; Siperstein MD
    Adv Intern Med; 1986; 31():309-40. PubMed ID: 3511622
    [No Abstract]   [Full Text] [Related]  

  • 13. Summaries of nursing care-related systematic reviews from the Cochrane Library: adenosine-diphosphate receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
    Zheng S; Min Z; Yanqing H
    J Cardiovasc Nurs; 2013; 28(5):405-6. PubMed ID: 23938327
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.
    Massi-Benedetti M; Federici MO
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S120-3. PubMed ID: 10522835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
    Peter R; Reilly E; Anthony S
    Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose control in type 2 diabetes: still worthwhile and worth pursuing.
    Kahn SE
    JAMA; 2009 Apr; 301(15):1590-2. PubMed ID: 19366780
    [No Abstract]   [Full Text] [Related]  

  • 18. Keeping the diabetic heart healthy.
    Harris M; Wan Q
    Aust Fam Physician; 2005 Jun; 34(6):441-5. PubMed ID: 15931402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular wall and diabetes mellitus: what complications and why?].
    Marre M
    Therapie; 1997; 52(5):371-4. PubMed ID: 9501559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"].
    Seufert J
    Dtsch Med Wochenschr; 2008 May; 133(20):1068-70. PubMed ID: 18461525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.